Review




Structured Review

BioNTech pfizer-biontech bivalent mrna vaccine
Pfizer Biontech Bivalent Mrna Vaccine, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer-biontech+bivalent+mrna+vaccine/pmc11706982-127-20-20?v=BioNTech
Average 90 stars, based on 1 article reviews
pfizer-biontech bivalent mrna vaccine - by Bioz Stars, 2026-08
90/100 stars

Images



Similar Products

90
BioNTech pfizer-biontech bivalent mrna vaccine
Pfizer Biontech Bivalent Mrna Vaccine, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer-biontech+bivalent+mrna+vaccine/pmc11706982-127-20-20?v=BioNTech
Average 90 stars, based on 1 article reviews
pfizer-biontech bivalent mrna vaccine - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
BioNTech pfizer-biontech covid-19 bivalent mrna vaccine (original omicron ba.1
Pfizer Biontech Covid 19 Bivalent Mrna Vaccine (Original Omicron Ba.1, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer-biontech+bivalent+mrna+vaccine/10__7883_slash_yoken__jjid__2024__116-1-19-19?v=BioNTech
Average 90 stars, based on 1 article reviews
pfizer-biontech covid-19 bivalent mrna vaccine (original omicron ba.1 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Moderna bivalent mrna vaccine or pfizer-biontech bivalent covid-19 vaccine dose
Bivalent Mrna Vaccine Or Pfizer Biontech Bivalent Covid 19 Vaccine Dose, supplied by Moderna, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer-biontech+bivalent+mrna+vaccine/pm38897685-78-21-24?v=Moderna
Average 90 stars, based on 1 article reviews
bivalent mrna vaccine or pfizer-biontech bivalent covid-19 vaccine dose - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
BioNTech pfizer-biontech bivalent covid-19 mrna vaccine
Characteristics of immunocompetent Medicare fee-for-service beneficiaries aged ≥65 years and beneficiaries aged ≥18 years with end stage renal disease receiving dialysis <xref ref-type= * without additional immunocompromising conditions, by receipt of bivalent mRNA COVID-19 vaccine — United States, September 2022–March 2023" width="250" height="auto" />
Pfizer Biontech Bivalent Covid 19 Mrna Vaccine, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer-biontech+bivalent+mrna+vaccine/pmc10794061-153-19-19?v=BioNTech
Average 90 stars, based on 1 article reviews
pfizer-biontech bivalent covid-19 mrna vaccine - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
BioNTech pfizer-biontech ba.4/5 bivalent mrna covid-19 vaccine
Characteristics of immunocompetent Medicare fee-for-service beneficiaries aged ≥65 years and beneficiaries aged ≥18 years with end stage renal disease receiving dialysis <xref ref-type= * without additional immunocompromising conditions, by receipt of bivalent mRNA COVID-19 vaccine — United States, September 2022–March 2023" width="250" height="auto" />
Pfizer Biontech Ba.4/5 Bivalent Mrna Covid 19 Vaccine, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer-biontech+bivalent+mrna+vaccine/pm37953096-25-3-3?v=BioNTech
Average 90 stars, based on 1 article reviews
pfizer-biontech ba.4/5 bivalent mrna covid-19 vaccine - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
BioNTech moderna pfizer-biontech bivalent mrna vaccines
Characteristics of immunocompetent Medicare fee-for-service beneficiaries aged ≥65 years and beneficiaries aged ≥18 years with end stage renal disease receiving dialysis <xref ref-type= * without additional immunocompromising conditions, by receipt of bivalent mRNA COVID-19 vaccine — United States, September 2022–March 2023" width="250" height="auto" />
Moderna Pfizer Biontech Bivalent Mrna Vaccines, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer-biontech+bivalent+mrna+vaccine/pm37730701-16-28-28?v=BioNTech
Average 90 stars, based on 1 article reviews
moderna pfizer-biontech bivalent mrna vaccines - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Characteristics of immunocompetent Medicare fee-for-service beneficiaries aged ≥65 years and beneficiaries aged ≥18 years with end stage renal disease receiving dialysis <xref ref-type= * without additional immunocompromising conditions, by receipt of bivalent mRNA COVID-19 vaccine — United States, September 2022–March 2023" width="100%" height="100%">

Journal: Morbidity and Mortality Weekly Report

Article Title: Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing COVID-19–Related Thromboembolic Events Among Medicare Enrollees Aged ≥65 Years and Those with End Stage Renal Disease — United States, September 2022–March 2023

doi: 10.15585/mmwr.mm7301a4

Figure Lengend Snippet: Characteristics of immunocompetent Medicare fee-for-service beneficiaries aged ≥65 years and beneficiaries aged ≥18 years with end stage renal disease receiving dialysis * without additional immunocompromising conditions, by receipt of bivalent mRNA COVID-19 vaccine — United States, September 2022–March 2023

Article Snippet: The signal was detected in a vaccinated concurrent comparator analysis and raised a question about whether receipt of a Pfizer-BioNTech bivalent COVID-19 mRNA vaccine increased the risk for an ischemic stroke event in the 21 days following vaccination in persons aged ≥65 years.

Techniques: Infection